Create a free Healthcare Packaging account to continue reading

FDA Proposes Rule for Wholesale Drug Distributors, Third-party Logistics Providers

If passed, the rule would allow only those licensed according to the proposed national standards to engage in transactions related to the sale and distribution of certain prescription drugs with other members of the supply chain.

The FDA has announced the availability of the proposed rule, National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers (Docket No. FDA-2020-N-1663), as required by the Drug Supply Chain Security Act (DSCSA).

The proposed rule would provide clarity and consistency for wholesale distributors and third-party logistics providers seeking licensure. Once the rule becomes final and effective, every U.S. wholesale distributor and third-party logistics facility will be held to these standards. Only those licensed according to the proposed national standards would be able to engage in transactions related to the sale and distribution of certain prescription drugs with other members of the supply chain.